π¦πΊπ¨π¦Lab Head @MonashBDI @VicHeartInst|Director @atheroaussie| Atherosclerosis,Obesity,macrophage inflammation| #macrophage_yogi|#positive_mentor| my opinion
A Queensland scientist is leading a world study that uncovered an inflammatory gene responsible for obesity. Blocking the gene could stop weight loss in its tracks, helping millions of Australians. https://t.co/VZ3A1cpmr5 @BrittanyCLane#7NEWS
Macrophages can engulf targets whole (phagocytosis) or nibble them in small fragments (trogocytosis), a decision controlled by cortical tension in the targets (high tension favors former, low latter)
https://t.co/bWqUvSxpRs
https://t.co/eBZHkmmHb6
@NatureCellBio@UCBerkeley
What if the future of treating heart disease could be a 'one-and-done' therapy?
A first in human gene-editing study, led by @ProfSNicholls, showed a reduction in LDL by up to 50% and triglycerides by 55% - with a single infusion.
π₯ Watch @AHAScience tv: https://t.co/eHViuoxfJc
π¨ Our new publication in Nature Communications!β¨ Macrophage WDFY3 protects against autoimmunity by boosting efferocytosis and dampening T cell activation.β¨
π‘οΈ A safeguard for immune homeostasis.
https://t.co/Uk6mxPny5I
Reminder that our obsession with journal names as a lazy proxy for "impact" is new.
Here are the key papers that led to the GLP-1 Lasker Award for Svetlana Mojsov:
Mojsov et al JBC 261:11880 1986
Mojsov et al JCI 79:616 1987
Mojsov et al JBC 265:8001 1990
Journal of Biological Chemistry
Journal of Clinical Investigation
In 1928, Alexander Fleming discovered the mould he was working with produced a substance that could kill many common bacteria. He called this new, exciting substance "mould juice". Only after a couple of months did he name it penicillin.
#WorldAntibioticAwarenessWeek
Victorian Heart Institute and Hospital Director @ProfSNicholls is leading world-first trials for genetic high cholesterol, expanding potentially life-saving treatments for those at risk of heart attack and stroke, presented at @American_Heart.
Read: https://t.co/OW8GpHS5Ha
Demoted four times and threatened with deportation, 2023 medicine laureate Katalin KarikΓ³'s journey in science was difficult but she persevered: "You have to channel all your energy into seeking out 'What's next? What can I do?'"
Listen to her interview: https://t.co/0m7AY99uLz
The ECR Rising Star Award Winner at the #AASASM24 was Dr Emma Solly. Congratulations on a fantastic contribution and exciting data. Thanks to CSL for sponsoring our Rising Stars.π
Our Director & CEO, Prof Elizabeth Hartland AM is among an impressive group of health & medical leaders named Fellows of the Australian Academy of Health & Medical Sciences. Congratulations @ProfHartland! π₯³
#AAHMSFellow@AAHMS_health
Read more here: https://t.co/ArCchd31mv
Huge congratulations to our Scientific Head, Prof James Whisstock, on his election as an #AAHMS Fellow for his contributions to the field of #immunology & beyond!
#proudPI. My Postdoc presented some exciting work within 3 mths of starting! Very exciting times. Congrats Narmadaa at being an AAS ECR Finalist @MonashVHI@MonashBDI
One of the highlights of the meeting is always seeing our Rising Stars shine and this morning it was the ECRs who did the shining! Dr Dragana Dragoljevic, Dr Emma Solly, Dr Jordyn Thomas & Dr Narmadaa Thyagarajan.
Our first national plenary was delivered by long time AAS member and lipoprotein expert, Prof Kerry-Anne Rye who talks us through their recent data in therapeutic options to reduce cardiometabolic disease.